• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

EPO Upholds Gilead Patent On Hep C Medicines, But In Amended Form

13/09/2018 by Catherine Saez, Intellectual Property Watch 1 Comment

[Updated] The European Patent Office (EPO) on 13 September ruled in favour of pharmaceutical company Gilead and maintained the company’s patent on hepatitis C drug sofosbuvir. The patent, however, is maintained in an amended form. Civil society involved in the case expressed dismay over the outcome and its potential effect on European drug prices.

Filed Under: IP Policies, Language, Themes, Venues, English, Europe, Health & IP, IP Law, Lobbying, Patents/Designs/Trade Secrets, Regional Policy

European Parliament Approves Negotiating Stance On Copyright Reform

12/09/2018 by Dugie Standeford for Intellectual Property Watch 1 Comment

European Union lawmakers today approved by a 438-226 margin a measure updating EU copyright law and voted to begin negotiations with the European Commission (EC) and Council. The vote followed parliamentary rejection in June of plans to launch an immediate “trilogue” with the EC and Council based on text as approved by the lead Legal Affairs Committee (JURI), instead sending the measure for full debate at the September plenary held today.

Filed Under: IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, Copyright Policy, Enforcement, English, Europe, Information and Communications Technology/ Broadcasting, Lobbying, Regional Policy

Civil Society Pushes EPO To Invalidate Hepatitis C Patent

12/09/2018 by Catherine Saez, Intellectual Property Watch 1 Comment

The European Patent Office is expected to hold oral proceedings later this week on a challenge filed against a Gilead patent on hepatitis C treatment. Invalidation of the patent would open the way to competition and lower prices, according to civil society groups which initiated the challenge. But according to an EPO source, the company is seeking at most an amendment to the patent.

Filed Under: IP Policies, Language, Themes, Venues, English, Europe, Health & IP, Innovation/ R&D, Patents/Designs/Trade Secrets, Regional Policy

European Commission Moves On Adoption Of WIPO GI Treaty; Timeframe Uncertain

12/09/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment

Over two years after a group of World Intellectual Property Organization members adopted a treaty on the protection of geographical indications, the European Commission has recommended that the European Union join the treaty. The EU was one of the major proponents of the treaty. Separately, a geographical indications industry group is urging EU attention to be placed on the need for legal certainty after the exit of the United Kingdom from the EU.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, Enforcement, English, Europe, Lobbying, Regional Policy, Trademarks/Geographical Indications/Domains, Traditional and Indigenous Knowledge, WIPO

New Dutch Foundation To Address High Medicines Pricing Announces Plan To File Complaint With Competition Authority

27/08/2018 by Intellectual Property Watch 1 Comment

The newly established Dutch Pharmaceutical Accountability Foundation has announced its first action to address unreasonably high medicines prices in the Netherlands. The Foundation will request the Netherlands Authority for Consumers and Markets to look into the price hike for the medicine chenodeoxycholic acid (CDCA) by the company Leadiant Biosciences Ltd (formerly Sigma-Tau). CDCA is used for the treatment of children and adults with cerebrotendinous xanthomatosis (CTX), a rare genetic metabolic disease that affects around 60 people in the Netherlands.

Filed Under: Features, Inside Views, IP Policies, Language, Themes, Venues, English, Europe, Finance, Health & IP, Human Rights, Patents/Designs/Trade Secrets, Regional Policy

New EPO Chief Outlines Priorities With Global Focus; Staff Wary But Hopeful

30/07/2018 by Dugie Standeford for Intellectual Property Watch Leave a Comment

Antonio Campinos, whose term as president of the European Patent Office began on 1 July, has said he wants to focus on the effectiveness of the organisation, greater global cooperation and “staff engagement.”

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, Bilateral/Regional Negotiations, English, Europe, Finance, Innovation/ R&D, Lobbying, Patents/Designs/Trade Secrets, Regional Policy, Technical Cooperation/ Technology Transfer

(Video) Europe’s Innovation Renaissance, China’s ‘Astonishing’ Rise: Global Innovation Index 2018

17/07/2018 by David Branigan, Intellectual Property Watch Leave a Comment

European countries led by Switzerland are experiencing an “innovation renaissance,” this year’s Global Innovation Index shows, while the scale of China’s rise in the index is “quite astonishing,” Sacha Wunsch-Vincent, senior economic officer at the World Intellectual Property Organization, says in a short video interview with Intellectual Property Watch.

Filed Under: Themes, Venues, Development, English, Europe, Finance, Innovation/ R&D, New Technologies, Regional Policy, WIPO

Albania Introduces New Trademark Regulation

17/07/2018 by Guest contributor for Intellectual Property Watch 1 Comment

A new trademark regulation entered into force in Albania on June 7, 2018, clarifying a range of issues raised by the changes to the Albanian Industrial Property Law in force as of March 24, 2017. Some of the most significant changes and clarifications concern the following:

Filed Under: IP Policies, Language, Themes, Venues, Contributors, English, Europe, IP Law, Regional Policy, Trademarks/Geographical Indications/Domains

European Parliament Rejects Starting Negotiations On Copyright Reform Proposal

05/07/2018 by Dugie Standeford for Intellectual Property Watch 2 Comments

The European Parliament today opposed plans to launch immediate “trilogue” negotiations with the Council and European Commission on copyright reform legislation, instead sending the controversial measure to full debate at the next plenary session of Parliament.

Filed Under: IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, Copyright Policy, English, Europe, Information and Communications Technology/ Broadcasting, Lobbying, Regional Policy

Controversial EU Parliament Copyright Reform Vote Tomorrow; 1,300 Musicians Urge Support

04/07/2018 by Intellectual Property Watch 1 Comment

The European Parliament votes tomorrow on whether to allow negotiations with the Council to begin on controversial copyright reform legislation. The proposed updated rules have sparked intense lobbying by supporters and foes alike, including, one lawmaker said at a press briefing today, death threats.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, Copyright Policy, Enforcement, English, Europe, Information and Communications Technology/ Broadcasting, Lobbying, Regional Policy

  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 130
  • Next Page »
  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2025 · Global Policy Reporting